Related Experiment Video
Updated: Mar 10, 2026

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
Published on: November 30, 2022
Giant Gastric Antral Ulcer Developing After Short-Term NSAID Administration
Tateki Yamane1, Takayuki Ishii2, Akira Umeda3
1Division of Gastroenterology, Department of Internal Medicine, The International University of Health and Welfare, Shioya Hospital, Japan.
Short-term NSAID use, specifically loxoprofen sodium hydrate, can rarely cause giant gastric ulcers. This case highlights the potential for serious gastrointestinal complications even after brief medication exposure.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain and inflammation.
- Loxoprofen sodium hydrate is a prodrug NSAID.
- Gastric ulcers are a known side effect of NSAID use.
Observation:
- A 61-year-old man presented with melena after a 5-day course of loxoprofen sodium hydrate for an upper respiratory infection.
- Upper gastrointestinal endoscopy revealed a giant, deeply undermined gastric ulcer in the antrum.
- The patient was negative for Helicobacter pylori infection.
Findings:
- The patient was diagnosed with an acute gastric ulcer induced by NSAID use.
- Giant gastric ulcers are rare, particularly those associated with short-term NSAID administration.
- This case demonstrates a rare instance of a huge gastric ulcer developing after brief NSAID exposure.
Implications:
- Clinicians should be aware of the potential for severe gastrointestinal complications, including giant gastric ulcers, even with short-term NSAID use.
- This case underscores the importance of considering NSAID-induced gastropathy in patients presenting with acute gastrointestinal bleeding.
- Further research may be warranted to understand the mechanisms behind rare, rapid-onset giant ulcer formation with NSAIDs.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease

